Concepedia
Statistics
Publications
17
Citations
388
H-Index
14
Active since
2013
Affiliations
MSD (France)(Current)
Cemka-Eval (France)
Inserm
Merck & Co., Inc., Rahway, NJ, USA (United States)
Université Paris Cité
L. Lévy-Bachelot is an author at MSD (France) specializing in medicine, pharmacoeconomics, and cost-effectiveness analysis.
Publications per year
2013–2020
Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France
C. Chouaïd, L. Bensimon, E. Clay et al. · Lung Cancer · 2018 · 71 citations · Full text
Medicine, Oncology, Pharmacoeconomics +17
Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis
B Charbonnel, Dominique Simon, Jean Dallongeville et al. · PharmacoEconomics - Open · 2017 · 45 citations · Full text
Pharmacy, Internal Medicine, Pharmacoeconomics +17
Quality of life and economic impact of refractory epilepsy in Spain: The ESPERA study
Vicente Villanueva, Jesús Martínez Girón, L.J. Hernández-Pastor et al. · Neurología (English Edition) · 2013 · 36 citations
Medicine, Neurology, Pharmacoeconomics +12
Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France
Laureen Majed, Xavier Bresse, Nadia El Mouaddin et al. · Vaccine · 2020 · 31 citations
Veterinary Medicine, Health Policy, Preventive Medicine +14
Outcomes following acute hospitalised myocardial infarction in France: An insurance claims database analysis
Patrick Blin, Philippe François, S. Bouée et al. · International Journal of Cardiology · 2016 · 24 citations
Medicine, Cardiology, Internal Medicine +14
1–5 of 17